주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Saturday, Aprill 20, 2024, 13:07
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Celltrion Completes US Patent Registration for Zymfentra
이미지기사
Healthcare & Bio
Jasmine Choi
04.12 10:16
Celltrion Obtains Recommendation for Marketing Authorization of Xolair Biosimilar ‘CT-P39’ in Europe
이미지기사
Healthcare & Bio
Jasmine Choi
03.26 07:53
Celltrion Submits Application for US Approval of ‘CT-P39’
이미지기사
Healthcare & Bio
Jasmine Choi
03.12 10:59
Samsung Bioepis Receives European Recommendation for Stelara Biosimilar Pyzchiva
이미지기사
Healthcare & Bio
Choi Mun-hee
02.26 08:32
Celltrion Confirms Safety in Phase 1 Trial of Oral Treatment for Autoimmune Diseases
이미지기사
Healthcare & Bio
Choi Mun-hee
02.07 11:17
Samsung Bioepis, Celltrion Entangled in Patent Disputes with Original Pharmaceutical Companies
이미지기사
Healthcare & Bio
Choi Mun-hee
02.02 14:20
Celltrion Applies for US FDA Approval of Actemra Biosimilar CT-P47
이미지기사
Healthcare & Bio
Jasmine Choi
01.30 11:18
Integrated Celltrion to Launch: Global Big Pharma Firm with 12 Trillion Won Revenue
이미지기사
Healthcare & Bio
Choi Mun-hee
2023.12.28 09:09
Celltrion Announces Phase 3 Clinical Trial Results for CT-P17, Humira
이미지기사
Healthcare & Bio
Jasmine Choi
2023.12.27 15:14
Celltrion Submits Application for FDA Approval of Prolia Biosimilar CT-P41
이미지기사
Healthcare & Bio
Jasmine Choi
2023.12.04 11:07
Samsung Bioepis, Celltrion Both Confirm Efficacy of Stelara Biosimilars
이미지기사
Healthcare & Bio
Jung Min-hee
2023.10.13 11:26
Celltrion Secures Additional FDA Approval for Yuflyma Dosages in US
이미지기사
Healthcare & Bio
Jasmine Choi
2023.10.05 02:56
Samsung Biologics Ranks 2nd in Newsweek’s Most Trusted Healthcare Companies Worldwide
이미지기사
Healthcare & Bio
Jasmine Choi
2023.09.08 18:27
Biopharmaceuticals Added to National Strategic Technology List, Eligible for Up to 35% Tax Deduction
이미지기사
Industries
Kim Eun-jin
2023.07.28 11:08
Samsung Biologics, Pfizer Announce Strategic Partnership
이미지기사
Industries
Jasmine Choi
2023.06.08 18:14
Celltrion Starts Development of Oral Form of Humira Biosimilar CT-P17
이미지기사
Science/Tech
Jasmine Choi
2023.06.05 19:58
Samsung Biologics Faced with Patent Lawsuit from Regeneron in US
이미지기사
Industries
Yoon Young-sil
2023.05.19 11:59
Samsung Chairman Talks Promotion with Pharma Giants, Bio-venture Startups in US
이미지기사
Industries
Jung Min-hee
2023.05.08 10:49
Samsung Biologics: All Eyes on Plant 5 and Samsung Bioepis
이미지기사
Finance
Lee Dong-gun
2023.01.04 09:32
Humira Biosimilar Market About to Open in the U.S.
이미지기사
Lifestyle
Jung Suk-yee
2022.12.13 12:28
처음
1
2
3
4
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기